Literature DB >> 3399796

Down-regulation of immunoglobulin and IgM-rheumatoid factor synthesis by oral treatment of rheumatoid arthritis patients with a nonsteroidal antiinflammatory drug.

M A Rodríguez1, M L Baroja, M Leon-Ponte, I L Stekman, I Abadi.   

Abstract

We examined the effect of treatment with piroxicam, a nonsteroidal antiinflammatory drug (NSAID), on immunoglobulin (Ig) and IgM-rheumatoid factor (IgM-RF) synthesis in vitro by lymphocytes of patients with rheumatoid arthritis (RA). Oral treatment with piroxicam induced a progressive decrease of spontaneous IgM-RF production by unstimulated lymphocyte cultures during 12 weeks of observation. Also, pokeweed mitogen (PWM)-driven Ig synthesis was significantly diminished and the effect on total IgM production was sustained until the end of the study. This modulation of humoral responses is consistent with the drop in RF sera level. In addition, we also showed that treatment with NSAIDs can decrease RF levels in the synovial space. NSAIDs may have a long-term beneficial effect in patients with RA due to their modulatory role of lymphocyte responses.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3399796     DOI: 10.1007/bf00271839

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  19 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  The T cell dependence of B cell differentiation induced by pokeweed mitogen.

Authors:  R G Keightley; M D Cooper; A R Lawton
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

3.  Endogenous prostaglandin E2 enhances polyclonal immunoglobulin production by tonically inhibiting T suppressor cell activity.

Authors:  J L Ceuppens; J S Goodwin
Journal:  Cell Immunol       Date:  1982-06       Impact factor: 4.868

4.  Role of prostaglandin in the depressed cell-mediated immune response in rheumatoid arthritis.

Authors:  S I Wolinsky; J S Goodwin; R P Messner; R C Williams
Journal:  Clin Immunol Immunopathol       Date:  1980-09

5.  Non-steroidal anti-inflammatory agent inhibit the synthesis of IgM rheumatoid factor in vitro.

Authors:  J L Ceuppens; M A Rodriguez; J S Goodwin
Journal:  Lancet       Date:  1982-03-06       Impact factor: 79.321

6.  The effects of anti-inflammatory drugs on prostaglandin production by rheumatoid synovial tissue.

Authors:  D R Robinson; M B McGuire; D Bastian; F Kantrowitz; L Levine
Journal:  Prostaglandins Med       Date:  1978-12

7.  Administration of nonsteroidal anti-inflammatory agents in patients with rheumatoid arthritis. Effects on indexes of cellular immune status and serum rheumatoid factor levels.

Authors:  J S Goodwin; J L Ceuppens; M A Rodriguez
Journal:  JAMA       Date:  1983-11-11       Impact factor: 56.272

8.  Analysis of the defects responsible for the impaired regulation of EBV-induced B cell proliferation by rheumatoid arthritis lymphocytes. II. Role of monocytes and the increased sensitivity of rheumatoid arthritis lymphocytes to prostaglandin E.

Authors:  F Hasler; H G Bluestein; N J Zvaifler; L B Epstein
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

9.  Piroxicam, a structurally novel anti-inflammatory compound. Mode of prostaglandin synthesis inhibition.

Authors:  T J Carty; J S Stevens; J G Lombardino; M J Parry; M J Randall
Journal:  Prostaglandins       Date:  1980-05

10.  Abnormal immunoglobulin and rheumatoid factor synthesis by blood lymphocytes in patients with primary Sjögren's syndrome.

Authors:  M A Rodriguez; M L Baroja; M Leon-Ponte; I Abadi
Journal:  Arthritis Rheum       Date:  1986-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.